Non-pharmaceutical interventions reduce likelihood of SARS-CoV-2 infection following high-risk exposure

NewsGuard 100/100 Score

Coronavirus disease 2019 (COVID-19) first arose in Wuhan, China. With few treatments, a rapid transmission rate, and high mortality among at-risk groups, it spread across the globe rapidly and has caused over 4.9 million deaths. In many countries, governments were forced to enact costly restrictions, including social distancing measures, mandatory face masks in public, and even complete lockdowns and stay-at-home orders. With the help of these restrictions, COVID-19 transmission rates were kept low while a vaccine was developed. However, there was some pushback to the harsh restrictions.

Study: Predictors of SARS-CoV-2 infection following high-risk exposure. Image Credit: Volurol/ ShutterstockStudy: Predictors of SARS-CoV-2 infection following high-risk exposure. Image Credit: Volurol/ Shutterstock

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Several countries suffered much-publicized protests and widespread misinformation (mostly focusing on face masks). Researchers from the University of California have been investigating the efficacy of many of the non-pharmaceutical interventions applied and exploring the theory that mask use results in less severe symptoms in individuals infected with severe acute respiratory disease coronavirus 2 (SARS-COV-2).

A preprint version of the group's study is available on the medRxiv* server while the article undergoes peer review.

The study

The researchers identified California residents who had received molecular SARS-CoV-2 test results reported to the California Department of Public Health between February and September 2021. Interviewers called random participants who had received test results in the preceding 48 hours, using those who had received negative results as controls. Cases were enrolled equally across the state, and interviewers attempted to have at least one control matched to each case for age group, sex, region, and week of test. Any participant who had not received a previous COVID-19 diagnosis or positive test result was eligible for inclusion.

The interviewers asked questions to assess the exposure, asking about social contact with infected individuals and whether these were suspected or confirmed. If any of the individuals had contact with a suspected case, follow-up questions were asked about the nature of the exposure; indoor/outdoor contact, duration, physical contact, use of face-covering, and whether or not the infected individual was a household member. All participants were then asked about their reasons for seeking testing, symptoms experienced, history of visiting any public places or participating in social gatherings, use of public transport, and vaccine status.

The researchers investigated a total of 2543 cases, 1280 positive cases, and 1263 controls. They used a conditional logistic regression model to estimate odds ratios and confidence intervals. These models included interactions between variables and vaccination history. Secondary analyses estimating the mask usage in both the controls and cases allowed the scientists to examine the effects of this condition in high-risk exposures. They further examined these variables' interactions with vaccination. They attempted to test the hypothesis that mask usage could reduce the severity of illness by examining the symptoms and level of medial response needed for individual cases.

Among the cases they examined, 847 reported high-risk exposure, 642 of which were infected in turn. Seven hundred forty-three of the high-risk exposures reported indoor contact, 613 reported contact over 3 hours, and 492 reported physical contact. The vast majority (694) reported neither of the contacts wore a mask, and 70% were unvaccinated.

The researchers reported no association with physical contact with the infected/suspected individual and case status. Still, household contact, mask-wearing, contact occurring indoors, and contact length also showed a significant risk of contracting the disease. Mask usage showed the strongest effect when contact occurred indoors or over three hours but also showed strong effects when physical contact occurred, or exposures involved household contacts. They discovered little connection between wearing masks and the severity of infection if the disease was contracted.

Conclusion

The authors highlight the importance of their study in providing evidence of the benefits of vaccination and social distancing measures in preventing the spread of SARS-CoV-2. They uncovered strong evidence of the benefits of mask-wearing, particularly with unvaccinated individuals the most in need. While there was no evidence of a reduction of symptomatic cases when masks were worn, the researchers worry that bias from individuals may have associated their likelihood with seeking testing.

These results could help inform public health policymakers and other researchers attempting to model the spread of the disease. As variants of concern continue to emerge, vaccination rates stall, and the UK begins to consider re-introducing some restrictions over winter, this study could help governments make scientifically based decisions to keep their countries safe.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • May 8 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Sam Hancock

Written by

Sam Hancock

Sam completed his MSci in Genetics at the University of Nottingham in 2019, fuelled initially by an interest in genetic ageing. As part of his degree, he also investigated the role of rnh genes in originless replication in archaea.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Hancock, Sam. (2023, May 08). Non-pharmaceutical interventions reduce likelihood of SARS-CoV-2 infection following high-risk exposure. News-Medical. Retrieved on April 18, 2024 from https://www.news-medical.net/news/20211026/Non-pharmaceutical-interventions-reduce-likelihood-of-SARS-CoV-2-infection-following-high-risk-exposure.aspx.

  • MLA

    Hancock, Sam. "Non-pharmaceutical interventions reduce likelihood of SARS-CoV-2 infection following high-risk exposure". News-Medical. 18 April 2024. <https://www.news-medical.net/news/20211026/Non-pharmaceutical-interventions-reduce-likelihood-of-SARS-CoV-2-infection-following-high-risk-exposure.aspx>.

  • Chicago

    Hancock, Sam. "Non-pharmaceutical interventions reduce likelihood of SARS-CoV-2 infection following high-risk exposure". News-Medical. https://www.news-medical.net/news/20211026/Non-pharmaceutical-interventions-reduce-likelihood-of-SARS-CoV-2-infection-following-high-risk-exposure.aspx. (accessed April 18, 2024).

  • Harvard

    Hancock, Sam. 2023. Non-pharmaceutical interventions reduce likelihood of SARS-CoV-2 infection following high-risk exposure. News-Medical, viewed 18 April 2024, https://www.news-medical.net/news/20211026/Non-pharmaceutical-interventions-reduce-likelihood-of-SARS-CoV-2-infection-following-high-risk-exposure.aspx.

Comments

  1. Chris Snyder Chris Snyder United States says:

    No mention if people were wearing well-sealing N95s.  Most any face covering will block infected respirtory droplets (given that covid isn't a "sneezing disease"), but an N95 should be worn around potentially infected people (assuming covid isn't tranferred by long-hanging aerosol).

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses